SyrhaTech joins CDMO France
Company

SyrhaTech joins CDMO France

SyrhaTech is proud to announce that we have joined the “CDMO France” association.


CDMO France brings together the main French, European and global pharmaceutical manufacturers, with drug production sites located in France. More than 80 industrial sites located in France are referenced.

The main activity of CDMO France’s members is the pharmaceutical manufacturing of healthcare products.

This is why SyrhaTech wanted to join CDMO France.


We are an aesthetic medical device company. Our customers operate all over the world and
their projects are often complex and ambitious.

SyrhaTech’s main activity is hydrogel prefilled syringe manufacturing. Whether for Dermal Filler products, or used in ophthalmology or orthopedics, no field of activity is excluded.

The pharmaceutical industry is constantly in need of new CDMO on the market, which is why SyrhaTech has chosen French know-how to set up its two manufacturing sites.

Our injectable products are made mainly from hyaluronic acid, but not only. Whether it’s your formulation or you’re looking for a ready-to-use product, SyrhaTech listens to your needs.

Do you have a project? Are you looking for a manufacturer?

Explore our environment

  • Company

    SyrhaTech, an aesthetic medical device company, between France and Switzerland

    The SyrhaTech team is made up of people from Europe’s four corners. Everyone is very…

    SyrhaTech, an aesthetic medical device company
  • Company

    SyrhaTech joins CDMO France

    SyrhaTech is proud to announce that we have joined the “CDMO France” association. CDMO France…

    SyrhaTech joins CDMO France
  • Company

    They Trust SyrHA : The Excellence of a CDMO

    At SyrHA, we believe that the cornerstone of our success is the unwavering trust that…

    Clients testimonials
  • Company

    Announcing strategic partnership : SyrHA the CDMO and ISHAS organization

    We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic…

  • Company

    CDMO: Evolution of their role

    Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past,…

    CDMO: Evolution of their role
  • Company

     Join us at IMCAS Paris! 

    We’re delighted to announce that our team will be taking part in the IMCAS 2024…

    IMCAS 2024 World Congress in Paris
  • Company

    SyrHATech is thrilled to install its new autoclave!

    In the field of sterile medical device manufacturing, the terminal sterilization of your products is…

    SyrHATech new autoclave
  • Company

    SyrHATech goes to CPHI Barcelona – from 10/24 to 10/26

    The CPHI (Convention on Pharmaceutical Ingredients) is the reference event for the pharmaceutical industry. Itinerant…

    CPHI Barcelona 2023
  • Company

    Inauguration of Syrhatech’s new premises in Geneva

    The Syrhatech team was delighted to share a convivial moment on its terrace on the…

    Inauguration of Syrhatech's new premises in Geneva
  • Company

    Development of a specific syringe for wrinkle filler

    Our customer contacts us to validate the design of a syringe made of plastic by…